JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, R.-Q.
Right arrow Articles by Dillon, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, R.-Q.
Right arrow Articles by Dillon, G. H.

Vol. 298, Issue 3, 986-995, September 2001

Pentylenetetrazole-Induced Inhibition of Recombinant gamma -Aminobutyric Acid Type A (GABAA) Receptors: Mechanism and Site of Action

Ren-Qi Huang, Cathy L. Bell-Horner, Mohammed I. Dibas, Douglas F. Covey, John A. Drewe and Glenn H. Dillon

Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, Texas (R.Q.H., C.B.H., M.I.D., G.H.D.); Department of Molecular Biology and Pharmacology, Washington University, St. Louis, Missouri (D.F.C.); and Cytovia, Inc., San Diego, California (J.A.D.)

Pentylenetetrazole (PTZ) is a central nervous system convulsant that is thought, based on binding studies, to act at the picrotoxin (PTX) site of the gamma -aminobutyric acid type A (GABAA) receptor. In the present study, we have investigated the mechanism and site of action of PTZ in recombinant GABAA receptors. In rat alpha 1beta 2gamma 2 receptors, PTZ inhibited GABA-activated Cl- current in a concentration-dependent, voltage-independent manner, with an IC50 of 0.62 ± 0.13 mM. The mechanism of inhibition appeared competitive with respect to GABA in both rat and human alpha 1beta 2gamma 2 receptors. Varying subunit configuration (change or lack of alpha  subunit isoform or lack of gamma 2 subunit) had modest effects on PTZ-induced inhibition, as evidenced by comparable IC50 values (0.6-2.2 mM) in all receptor configurations tested. This contrasts with PTX and other PTX-site ligands, which have greater affinity in receptors lacking an alpha  subunit. Using a one-site model for PTZ interaction with alpha 1beta 2gamma 2 receptors, the association rate (k+1) was found to be 1.14 × 103 M-1 s-1 and the dissociation rate (k-1) was 0.476 s-1, producing a functional kd of 0.418 mM. PTZ could only gain access to its binding site extracellularly. Single-channel recordings demonstrated that PTZ decreased open probability by increasing the duration of closed states but had no effect on single-channel conductance or open state duration. alpha -Isopropyl-alpha -methyl-gamma -butyrolactone, a compound known to antagonize effects of PTX, also diminished the effects of PTZ. Taken together, our results indicate that pentylenetetrazole and picrotoxin interact with overlapping but distinct domains of the GABAA receptor.


0022-3565/01/2983-0986$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.